Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

AstraZeneca PLC ADR

AZN
Current price
79.59 USD +0.06 USD (+0.08%)
Last closed 79.53 USD
Sector Healthcare
Industry Drug Manufacturers - General
Exchange NASDAQ
Capitalization 246 149 169 152 USD
Yield for 12 month +5.81 %
1Y
3Y
5Y
10Y
15Y
AZN
21.11.2021 - 28.11.2021

AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company's marketed products include Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Farxiga, Brilinta, Lokelma, Roxadustat, Andexxa, Crestor, Seloken, Onglyza, Bydureon, Fasenra, Breztri, Symbicort, Saphnelo, Tezspire, Pulmicort, Bevespi, and Daliresp for cardiovascular, renal, metabolism, and oncology. Its marketed products also comprise Vaxzevria, Beyfortus, Synagis, FluMist, Soliris, Ultomiris, Strensiq, Koselugo, and Kanuma for covid-19 and rare disease. The company serves primary care and specialty care physicians through distributors and local representative offices in the United Kingdom, rest of Europe, the Americas, Asia, Africa, and Australasia. It has a collaboration agreement with Neurimmune AG to develop and commercialize NI006. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom. Address: 1 Francis Crick Avenue, Cambridge, United Kingdom, CB2 0AA

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

86.92 USD

P/E ratio

39.1083

Dividend Yield

1.82 %

Current Year

+45 811 000 000 USD

Last Year

+44 351 000 000 USD

Current Quarter

+12 679 000 000 USD

Last Quarter

+12 024 000 000 USD

Current Year

+37 543 000 000 USD

Last Year

+31 960 000 000 USD

Current Quarter

+9 536 000 000 USD

Last Quarter

+9 716 000 000 USD

Key Figures AZN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 15 802 999 808 USD
Operating Margin TTM 26.11 %
PE Ratio 39.1083
Return On Assets TTM 7.04 %
PEG Ratio 0.8861
Return On Equity TTM 17.29 %
Wall Street Target Price 86.92 USD
Revenue TTM 47 610 998 784 USD
Book Value 24.17 USD
Revenue Per Share TTM
Dividend Share 2.9 USD
Quarterly Revenue Growth YOY 16.5 %
Dividend Yield 1.82 %
Gross Profit TTM 35 732 000 000 USD
Earnings per share 2.03 USD
Diluted Eps TTM 2.03 USD
Most Recent Quarter I 2024
Quarterly Earnings Growth YOY 20.7 %
Profit Margin 13.3 %

Dividend Analytics AZN

Dividend growth over 5 years

6 %

Continuous growth

Payout Ratio 5 years average

834 %

Dividend History AZN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate 1.45
Ex Dividend Date 22.02.2024
Forward Annual Dividend Yield 1.82 %
Last Split Factor 2:1
Payout Ratio 39.08 %
Last Split Date 27.07.2015
Dividend Date 25.03.2024

Stock Valuation AZN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE 39.1083
Forward PE 16.3132
Enterprise Value Revenue 5.1971
Price Sales TTM 4.6651
Enterprise Value EBITDA 17.7384
Price Book MRQ 5.4598

Financials AZN

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators AZN

For 52 weeks

59.55 USD 80.86 USD
50 Day MA 75 USD
Shares Short Prior Month 7 665 396
200 Day MA 68.21 USD
Short Ratio 1.37
Shares Short 6 667 770
Short Percent 0.27 %

Dynamics of changes in the value of assets

Stocks


AAPL

AAPL

212.49 USD Apple Inc -1.32 (-0.62%)
Detailed analytics

ETF funds


S

SX7EEX

13.36 EUR iShares EURO STOXX Banks 30-15 UCITS ETF (DE) -0.53 (-3.54%)
Detailed analytics

Metals


Gold

2332.52 USD Gold +27.54 (+1.2%)
Detailed analytics